Simoneit Diona's Form 4/A amendment
AmendedStarling Oncology, Inc. (DFPH) · filed Nov 22, 2022
- Accession no.
- 0001799191-22-000053
- Filed
- Nov 22, 2022
- Trade date
- Nov 15, 2022
- Filing delay
- 7 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Nov 17, 2022
This filing lists 1 non-derivative transaction. Open-market sales total $385.7. It was filed 7 days after the trade.
This amendment replaces 0001799191-22-000015 (filed Nov 17, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Simoneit DionaCIK 0001921432 | Officer (Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | Common Stock | SSaleDisposed | −190 | $2.03 | −$385.7 | 29,318 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.